Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium

JASINT 1

Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium

Hide study title
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
80
Years old
Gender
All
Therapeutic area :
Oncology
Disease :
Carcinoma of the urothelium
Study medication :
Vinflunine (Javlor®)
Phase : Phase II
Start Date :
05 October 2010
End date :
22 November 2010
Study ID : L00070 IN 213 PI
EudraCT/CTIS number : 2010-020620-22

Results

Public links :

Send by email